Rosenblatt Securities Reiterates Buy Rating for Dolby Laboratories (NYSE:DLB)

Dolby Laboratories (NYSE:DLB)‘s stock had its “buy” rating reaffirmed by investment analysts at Rosenblatt Securities in a report issued on Friday,Benzinga reports. They presently have a $85.00 price objective on the electronics maker’s stock. Rosenblatt Securities’ price target would suggest a potential upside of 35.16% from the company’s current price.

A number of other research analysts have also recently weighed in on DLB. Barrington Research dropped their target price on shares of Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating on the stock in a research note on Monday. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 29th. Finally, Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Monday, January 5th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Dolby Laboratories has a consensus rating of “Moderate Buy” and a consensus target price of $90.75.

Dolby Laboratories Trading Up 2.8%

DLB stock opened at $62.89 on Friday. The stock has a market cap of $6.01 billion, a P/E ratio of 23.91 and a beta of 0.88. The stock’s fifty day simple moving average is $65.14 and its two-hundred day simple moving average is $68.95. Dolby Laboratories has a 1-year low of $60.14 and a 1-year high of $89.66.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Thursday, January 29th. The electronics maker reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.16. The company had revenue of $346.71 million for the quarter, compared to analysts’ expectations of $341.26 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%. As a group, analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, EVP Mark Andrew Sherman sold 2,491 shares of the stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $67.26, for a total transaction of $167,544.66. Following the sale, the executive vice president owned 70,563 shares of the company’s stock, valued at approximately $4,746,067.38. This represents a 3.41% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $65.55, for a total value of $196,650.00. Following the transaction, the senior vice president directly owned 67,435 shares of the company’s stock, valued at $4,420,364.25. The trade was a 4.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 137,120 shares of company stock valued at $9,184,809. 37.93% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of DLB. First Horizon Corp bought a new stake in Dolby Laboratories during the third quarter valued at approximately $25,000. Hantz Financial Services Inc. raised its position in shares of Dolby Laboratories by 166.7% during the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after buying an additional 220 shares in the last quarter. Allworth Financial LP raised its position in shares of Dolby Laboratories by 590.4% during the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock valued at $37,000 after buying an additional 431 shares in the last quarter. Mather Group LLC. bought a new stake in shares of Dolby Laboratories during the 3rd quarter worth $38,000. Finally, Rothschild Investment LLC grew its position in Dolby Laboratories by 4,046.7% in the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock worth $45,000 after acquiring an additional 607 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.

More Dolby Laboratories News

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Dolby raised FY‑2026 and Q2 guidance well above prior Street expectations — management now targets FY EPS roughly in the mid‑$4s and Q2 EPS of $1.29–$1.44, with revenue ranges above consensus. This is the main bullish catalyst supporting upside conviction. PR Newswire: Dolby Laboratories Reports First Quarter 2026 Financial Results
• Positive Sentiment: Q1 results beat headline estimates: revenue ~$346.7M and EPS $1.06 topped consensus, showing resilience in top‑line and headline profitability versus forecasts. Beating the print supported management’s confidence in the outlook. MarketBeat: Q1 results summary
• Positive Sentiment: Street reaction includes at least one analyst upgrade and commentary that Dolby’s valuation looks more attractive after the quarter, which can support positive analyst momentum and higher price targets. Seeking Alpha: Rating upgrade
• Neutral Sentiment: Management commentary and the earnings‑call transcript highlight confidence in content partnerships and product roadmaps; investors can review the call transcript/highlights for detail on customer wins, product mix and margin cadence. Yahoo Finance: Q1 highlights
• Negative Sentiment: Third‑party coverage flagged weaker operating profitability and cash‑flow metrics in the quarter (lower operating profit, declining operating cash flow in certain reports), which prompted some short‑term selling after the release. That mixed internal sizing of growth vs. margin pressure is weighing on the stock. QuiverQuant: Mixed metrics & stock reaction
• Negative Sentiment: Earlier analyst downgrades and a recent one‑year low callout have kept downward pressure on sentiment; investors sensitive to near‑term multiples or margin volatility may remain cautious. American Banking News: 1‑year low on downgrade

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.